Testosterone Plays a Permissive Role in Angiotensin II-induced Hypertension and Cardiac Hypertrophy in Male Rats
Overview
Affiliations
Sex hormones contribute to sex differences in blood pressure. Inappropriate activation of the renin-angiotensin system is involved in vascular dysfunction and hypertension. This study evaluated the role of androgens (testosterone) in angiotensin II (Ang II)-induced increase in blood pressure, vascular reactivity, and cardiac hypertrophy. Eight-week-old male Wistar rats underwent sham operation, castration, or castration with testosterone replacement. After 12 weeks of chronic changes in androgen status, Ang II (120 ng/kg per minute) or saline was infused for 28 days via subcutaneous miniosmotic pump, and changes in blood pressure was measured. Vascular reactivity and Ang II receptor levels were examined in mesenteric arteries. Heart weight, cardiac ANP mRNA levels, and fibrosis were also assessed. Ang II infusion increased arterial pressure in intact males. The Ang II-induced increase in hypertensive response was prevented in castrated males. Testosterone replacement in castrated males restored Ang II-induced hypertensive responses. Castration reduced vascular AT1R/AT2R ratio, an effect that was reversed by testosterone replacement. Ang II-induced hypertension was associated with increased contractile response of mesenteric arteries to Ang II and phenylephrine in intact and testosterone-replaced castrated males; these increases were prevented in castrated males. Ang II infusion induced increased left ventricle-to-body weight ratio and ANP mRNA expression, indicators of left ventricular hypertrophy, and fibrosis in intact and testosterone-replaced castrated males, and castration prevented the increase in these parameters caused by Ang II. This study demonstrates that testosterone plays a permissive role in development and maintenance of Ang II-induced vascular dysfunction, hypertension, and cardiac hypertrophy.
Salt sensitivity of blood pressure: mechanisms and sex-specific differences.
Masenga S, Wandira N, Cattivelli-Murdoch G, Saleem M, Beasley H, Hinton Jr A Nat Rev Cardiol. 2025; .
PMID: 39984695 DOI: 10.1038/s41569-025-01135-0.
Cross-Sex Hormone Therapy Is Associated With Loss of Circadian Rhythm in the Male Rat.
Mallette J, Crudup B, Oudomrath Speyrer A, Rawls A, Cockrell K, Willis A Hypertension. 2024; 82(2):241-254.
PMID: 39633591 PMC: 11735301. DOI: 10.1161/HYPERTENSIONAHA.124.23901.
The role of age and sex in non-linear dilution adjustment of spot urine arsenic.
Carmine T BMC Nephrol. 2024; 25(1):348.
PMID: 39396936 PMC: 11475607. DOI: 10.1186/s12882-024-03758-w.
Bracamonte J, Watkins L, Pat B, DellItalia L, Saucerman J, Holmes J bioRxiv. 2024; .
PMID: 39345523 PMC: 11429691. DOI: 10.1101/2024.09.12.612768.
Revisiting sex as a biological variable in hypertension research.
Ryan M, Clemmer J, Mathew R, Faulkner J, Taylor E, Abais-Battad J J Clin Invest. 2024; 134(17).
PMID: 39225093 PMC: 11364402. DOI: 10.1172/JCI180078.